A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis
Study sponsor: Karyopharm Therapeutics Inc · KPTI
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2026-09Estimated
Enrollment · participants112Estimated
Source updated2026-07-02Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.